Melatonin Market Growth Accelerated by Rising Healthcare Expenditure
Melatonin is a hormone that
regulates sleep-wake cycles. Oral melatonin supplements are used as sleep aids
and to treat circadian rhythm disorders. They help induce sleep, improve sleep
quality and overcome jet lag. With rising stress levels and hectic lifestyles,
sleep disorders have become increasingly common. This has driven up demand for
over-the-counter sleep supplements. The global melatonin market is estimated to
be valued at US$ 576.85 Mn in 2023
and is expected to exhibit a 12% CAGR
over the forecast period 2023 to 2030, as highlighted in a new report published
by Coherent Market Insights.
Market key trends:
The increasing healthcare expenditure globally has been a major driver of the
melatonin market. As disposable incomes rise, people are willing to spend more
on their health and well-being. Sleep disorders can have serious health
consequences if left untreated for prolonged periods. Patients are turning to
melatonin supplements as an affordable and natural treatment alternative. This
has supported sales growth. Furthermore, growing health awareness and focus on
preventive healthcare is encouraging more people to use supplements for
conditions like insomnia. The market is expected to continue expanding on the
back of rising healthcare spending in developing nations.
Segment
Analysis
Melatonin is largely categorized into three major sub-segments: capsules and
tablets, liquids, and granules and powders. Among them, capsules and tablets
dominate the market, occupying over 50% market share in 2024. Their higher
efficacy and controlled-release properties make capsules and tablets a
preferred form among consumers. However, liquids and granules are gaining
popularity due to ease of ingestion and accurate dosing.
Key Takeaways
The Global
Melatonin Market Size is expected to witness high growth over the
forecast period.
Regional
analysis:
North America dominates the global market and is expected to maintain its lead
position during the forecast period. High adoption of melatonin supplements for
its sleep-inducing effects and treatment of depression and anxiety disorders is
driving the North American market. Europe follows North America in terms of
market share. Favorable reimbursement policies and growing geriatric population
suffering from age-related health issues are some factors responsible for
Europe's large market size.
Key players operating in the melatonin market are C.H. Boehringer Sohn AG &
Ko. KG, Pfizer Inc., Eli Lilly and Company, AstraZeneca plc, Natco Pharma
Limited, Anhui Haikang Pharmaceutical Co., Ltd., Avra Laboratories Pvt. Ltd.,
and Sun Pharmaceutical Industries Ltd.
For
More Insights, Read: https://www.newswirestats.com/melatonin-market-demand-growth-and-regional-outlook-by-2030/
Related Reports: https://www.newsintv.com/sports/eurothrills-unleashing-sporting-excellence-with-europes-finest-gear-and-game/
Comments
Post a Comment